{"nct_id":"NCT01234402","title":"Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients","status":"COMPLETED","status_verified_date":"2019-07","start_date":"2011-03","start_date_type":null,"primary_completion_date":"2013-10","primary_completion_date_type":"ACTUAL","completion_date":"2017-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["LLY"]}